Performance of magnetic chitosan-alginate core-shell beads for increasing the bioavailability of a low permeable drug

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 88, Issue 2, 2014, Pages 374-381

  Seth, Anjali ^a,b   Lafargue, David ^b   Poirier, Cécile ^b   Péan, Jean Manuel ^b   Ménager, Christine ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b INSTITUT DE RECHERCHES INTERNATIONALES SERVIER   (France)

Author keywords

Absorption; Alginate; Bioavailability; Chitosan; Drug delivery; Magnetic particles

Indexed keywords

ALGINIC ACID; AMILORIDE; CANDESARTAN; CHITOSAN DERIVATIVE; FUROSEMIDE; GLUCOSE; HYDROCHLOROTHIAZIDE; LAMOTRIGINE; NANOBEAD; NANOSHELL; NORFLOXACIN; ONDANSETRON; PRAVASTATIN; SALAZOSULFAPYRIDINE; VERAPAMIL; CHITOSAN; GLUCURONIC ACID; HEXURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG PENETRATION; DRUG SOLUBILITY; EX VIVO STUDY; HUMAN; IN VITRO STUDY; MAGNETIC FIELD; MALE; MUCOADHESION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; STOMACH PH; ANIMAL; BIOAVAILABILITY; CHEMISTRY; MAGNETISM; PERMEABILITY; PHARMACOKINETICS; SCANNING ELECTRON MICROSCOPY; WISTAR RAT;

ALGINATES; ANIMALS; BIOLOGICAL AVAILABILITY; CHITOSAN; GLUCURONIC ACID; HEXURONIC ACIDS; HUMANS; MAGNETICS; MALE; MICROSCOPY, ELECTRON, SCANNING; PERMEABILITY; PHARMACOKINETICS; RATS; RATS, WISTAR;

EID: 84908366127     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.05.017     Document Type: Article

References (35)

1. FDA, Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms based on a Biopharmaceutics, Classification System, 2000.
2. M. Lindenberg, S. Kopp, and J.B. Dressman Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system Eur. J. Pharm. Biopharm. 58 2004 265 278
3. H. Chen, and R. Langer Oral particulate delivery: status and future trends Adv. Drug. Delivery Rev. 34 1998 339 350
4. X. Li, S. Guo, C. Zhu, Q. Zhu, Y. Gan, and J. Rantanen Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles Biomaterials 34 2013 9678 9687
5. S.S. Davis Formulation strategies for absorption windows Drug Discov. Today 10 2005 249 257
6. A.K. Nayak, R. Maji, and B. Das Gastroretentive drug delivery systems: a review Asian J. Pharm. Clin. Res. 3 2010 2 10
7. G.P. Andrews, T.P. Laverty, and D.S. Jones Mucoadhesive polymeric plateforms for controlled drug delivery Eur. J. Pharm. Biopharm. 71 2009 505 518
8. S. Eiamtrakarn, Y. Itoh, J. Kishimoto, Y. Yoshikawa, N. Shibata, and M. Murakami Gastrointestinal mucoadhesive patch system (GI-MAPS) for oral administration of G-CSF, a model protein Biomaterials 23 2002 145 152
9. K. Whitehead, Z. Shen, and S. Mitragotri Oral delivery of macromolecules using intestinal patches: applications for insulin delivery J. Controlled Release 98 2004 37 45
10. D. Zhang, P. Sun, P. Li, A. Xue, X. Zhang, and H. Zhang A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette-Guérin in the treatment of bladder cancer Biomaterials 34 2013 10258 10266
11. P.L. Bardonnet, V. Faivre, W.J. Pugh, J.C. Piffaretti, and F. Falson Gastroretentive dosage forms: overview and special case of Helicobacter pylori J. Controlled Release 111 2006 1 18
12. U.O. Häfeli Magnetically modulated therapeutic systems Int. J. Pharm. 277 2004 19 24
13. B. Laulicht, A. Tripathi, V. Schlageter, P. Kucera, and E. Mathiowitz Understanding gastric forces calculated from high-resolution pill tracking PNAS 107 2010 8201 8206
14. B. Laulicht, N.J. Gidmarkb, A. Tripathic, and E. Mathiowitz Localization of magnetic pills PNAS 108 2011 2252 2257
15. R. Guignet, G. Bergonzelli, V. Schlageter, M. Turini, and P. Kucera Magnet tracking: a new tool for in vivo studies of the rat gastrointestinal motility Neurogastroenterol. Motil. 18 2006 472 478
16. A. Steingoetter, D. Weishaupt, P. Kunz, K. Mäder, H. Lengsfeld, and M. Thumshirn Magnetic resonance imaging for the in vivo evaluation of gastric-retentive tablets Pharm. Res. 20 2003 2001 2007
17. J. Cheng, B.A. Teply, S. Yoon Jeong, C.H. Yim, D. Ho, and I. Sherifi Magnetically responsive polymeric microparticles for oral delivery of protein drugs Pharm. Res. 23 2006 557 564
18. B.A. Teply, R. Tong, S.Y. Jeong, G. Luther, I. Sherifi, and C.H. Yim The use of charge-coupled polymeric microparticles and micromagnets for modulating the bioavailability of orally delivered macromolecules Biomaterials 29 2008 1216 1223
19. J.K. Vasir, K. Tambwekar, and S. Garg Bioadhesive microspheres as a controlled drug delivery system Int. J. Pharm. 255 2003 13 32
20. R. Massart Preparation of aqueous magnetic liquids in alkaline and acidic media IEEE Trans. Mag. 17 1981 1247 1248
21. F.Q. Wang, P. Li, J.P. Zhang, A.Q. Wang, and Q. Wei PH-sensitive magnetic alginate-chitosan beads for albendazole delivery Pharm. Dev. Technol. 16 2011 228 236
22. K. Suknuntha, V. Tantishaiyakul, N. Worakul, and W. Taweepreda Characterization of muco- and bioadhesive properties of chitosan, PVP, and chitosan/PVP blends and release of amoxicillin from alginate beads coated with chitosan/PVP Drug Dev. Ind. Pharm. 37 2011 408 418
23. R. Hejazi, and M. Amiji Chitosan-based gastrointestinal delivery systems J. Controlled Release 89 2003 151 165
24. M. George, and T.E. Abraham Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan - a review J. Controlled Release 114 2006 1 14
25. P.R. Hari, T. Chandy, and C.P. Sharma Chitosan/calcium-alginate beads for oral delivery of insulin J. Appl. Polym. Sci. 59 1996 1795-80
26. A.D. Sezer, and J. Akbuga Release characteristics of chitosan treated alginate beads: I. Sustained release of a macromolecular drug from chitosan treated alginate beads J. Microencapsul. 16 1999 195 203
27. U. Fagerholm, M. Johansson, and H. Lennernas Comparaison between permeability coefficients in rat and human jejunum Pharm. Res. 13 1996 1336 1342
28. Å. Sjöberg, M. Lutz, C. Tannergren, C. Wingolf, A. Borde, and A.L. Ungell Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique Eur. J. Pharm. Sci. 48 2013 166 180
29. H. Lennernäs, S. Nylander, and A.L. Ungell Jejunal permeability: a comparison between the Ussing chamber technique and the single-pass perfusion in humans Pharm. Res. 14 1997 667 671
30. A.L. Ungell In vitro absorption studies and their relevance to absorption from the GI tract Drug Dev. Ind. Pharm. 23 1997 879 892
31. M. Boisset, R.P. Botham, K.D. Haegele, B. Lenfant, and J.I. Pachot Absorption of angiotensin II antagonists in Ussing chambers, Caco-2, perfused jejunum loop and in vivo: Importance of drug ionisation in the in vitro prediction of in vivo absorption Eur. J. Pharm. Sci. 10 2000 215 224
32. H. Chen, and R. Langer Magnetically-responsive polymerized liposomes as potential oral delivery vehicles Pharm. Res. 14 1997 537 540
33. R. Gröning, M. Berntgen, and M. Georgarakis Acyclovir serum concentrations following peroral administration of magnetic depot tablets and the influence of extracorporal magnets to control gastrointestinal transit Eur. J. Pharm. Biopharm. 46 1998 285 291
34. J. Fujimori, Y. Machida, S. Tanaka, and T. Nagai Effect of magnetically controlled gastric residence of sustained release tablets on bioavailability of acetaminophen Int. J. Pharm. 119 1995 47 55
35. E.L. Silva, J.F. Carvalho, T.R.F. Pontes, E.E. Oliveira, B.L. Francelino, and A.C. Medeiros Development of a magnetic system for the treatment of Helicobacter pylori infections J. Magn. Magn. Mater. 321 2009 1566 1570